In 2022, the cold sore treatment market was estimated to be worth USD 825.24 million. Over the course of the forecast period, a compound annual growth rate (CAGR) of 6.6% is anticipated. A cold sore develops around the mouth or on the lips. One of the main factors propelling the market's growth is the increasing incidence of HSV infection worldwide.
HSV raises the risk of contracting and spreading HIV infection as well as serious side effects like encephalitis. This is one of the main drivers propelling the market's growth, along with the growing number of people suffering from chronic illnesses. The market is expanding as a result of rising healthcare spending and increased investments in developing healthcare infrastructure globally.

Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/cold-sore-treatment-market

Growth Drivers
Effective therapy is still in high demand due to the high prevalence of the Herpes simplex virus. Patients benefit from increased effectiveness and convenience as a result of ongoing research and development into novel treatment alternatives, such as topical creams and antiviral drugs. Demand for over-the-counter treatments is fueled by a greater public understanding of the value of early treatment and preventative actions. Stress, a compromised immune system, and exposure to triggers are some of the factors that make breakouts more often, which makes people look for effective therapies.
Online platforms and e-commerce facilities have made cold sore treatments more accessible, which facilitates purchases and expands the market reach. The market is expanding due to rising demand for antiviral drugs used to treat cold sores. In addition to painkillers, lip balms and lotions are being used more frequently for therapeutic purposes.
Segmentation
Therapeutics Type
· Antiviral Agents
· Analgesic Agents
· Lysine
· Propolis
· Penciclovir
· Famciclovir
· Rhubarb and Sage
· Acyclovir
· Others
Drug Type
· Branded
· Generics
End-Users
· Home-Care
· Specialty Clinics
· Others
Distribution Channel
· Hospital Pharmacy
· Online Pharmacy
· Retail Pharmacy
· Others
Dosage Form
· Tablet
· Capsule
· Ointment
· Others
Regional Outlook
· Asia Pacific
· North America
· Latin America
· Europe
· Middle East and Africa
Key Players
· Pfizer
· Novartis
· GlaxoSmithKline plc
· Teva Pharmaceuticals Industries ltd.
· Sanofi
· AstraZeneca
· Bayer AG
· Merck. and Co.
· Aurobindo Pharma
· Bausch Health Companies
· Eli Lilly and Company
· Bristol Myers Squibb Company
· Cipla Inc.
· Other Players

For More Information about this Report @ https://www.xresearch.biz/shop/cold-sore-treatment-market

About Us: -
xResearch is a market research and consulting organization that uses unique data, expert analysis, and new technologies to create trusted intelligence on industries. Our research is focused on delivering an informed and impartial view on essential market data of industry, and it is primarily driven by an in-depth study covering the following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.

Contact:
Company Name: xResearch
Contact Person: James Lin
Email: [email protected]
Phone: +1 718-619-8140
Websites: https://www.xresearch.biz/